2023
Thermostable FGF2 Polypeptide, Use Thereof
DVOŘÁK, Petr; Pavel KREJČÍ; Lukáš BÁLEK; Lívia EISELLEOVÁ; Žaneta KONEČNÁ et. al.Basic information
Original name
Thermostable FGF2 Polypeptide, Use Thereof
Name (in English)
Thermostable FGF2 Polypeptide, Use Thereof
Authors
DVOŘÁK, Petr (203 Czech Republic, belonging to the institution); Pavel KREJČÍ (203 Czech Republic, belonging to the institution); Lukáš BÁLEK (203 Czech Republic, belonging to the institution); Lívia EISELLEOVÁ (703 Slovakia, belonging to the institution); Žaneta KONEČNÁ (203 Czech Republic, belonging to the institution); Pavel DVOŘÁK (203 Czech Republic, belonging to the institution); David BEDNÁŘ (203 Czech Republic, belonging to the institution); Jan BREZOVSKÝ (203 Czech Republic, belonging to the institution); Eva ŠEBESTOVÁ (203 Czech Republic, belonging to the institution); Radka CHALOUPKOVÁ (203 Czech Republic, belonging to the institution); Veronika ŠTĚPÁNKOVÁ; Pavel VAŇÁČEK; Zbyněk PROKOP; Jiří DAMBORSKÝ (203 Czech Republic, belonging to the institution) and Michaela BOSÁKOVÁ (203 Czech Republic, belonging to the institution)
Edition
Number: IN485239, Publisher: Intellectual Property India, Place of publication: Dwarka, New Delhi, Owner's name: Masarykova univerzita; Enantis s.r.o. 2023
Other information
Language
Hindi
Type of outcome
Patent
Country of publisher
India
Confidentiality degree
is not subject to a state or trade secret
References:
RIV identification code
RIV/00216224:14310/23:00133874
Organization
Přírodovědecká fakulta – Repository – Repository
Keywords in English
Fibroblast Growth Factor 2; FGF2
Changed: 7/8/2024 00:50, RNDr. Daniel Jakubík
V originále
The present invention relates to engineered Fibroblast Growth Factor 2 (FGF2, bFGF) having improved thermal stability compared to the wild-type and the use thereof in the cell biology research, regenerative medicine and related medical applications or cosmetics. The present invention further relates to a culture medium comprising FGF2 suitable for culturing a human pluripotent stem cells involving both human embryonic stem cells and induced pluripotent stem cells.
In English
The present invention relates to engineered Fibroblast Growth Factor 2 (FGF2, bFGF) having improved thermal stability compared to the wild-type and the use thereof in the cell biology research, regenerative medicine and related medical applications or cosmetics. The present invention further relates to a culture medium comprising FGF2 suitable for culturing a human pluripotent stem cells involving both human embryonic stem cells and induced pluripotent stem cells.
